These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 24088099

  • 1. Clinical decisions. Glycemic management in a patient with type 2 diabetes.
    Hirsch IB, Molitch ME.
    N Engl J Med; 2013 Oct 03; 369(14):1370-2. PubMed ID: 24088099
    [No Abstract] [Full Text] [Related]

  • 2. Clinical decisions. Management of type 2 diabetes.
    Goldberg RB, Holman R, Drucker DJ.
    N Engl J Med; 2008 Jan 17; 358(3):293-7. PubMed ID: 18199869
    [No Abstract] [Full Text] [Related]

  • 3. Oral combination therapy in primary care.
    Kalra S, Gupta Y.
    J Pak Med Assoc; 2015 May 17; 65(5):574-5. PubMed ID: 26028398
    [Abstract] [Full Text] [Related]

  • 4. Clinical use of dipeptidyl peptidase-4 and sodium-glucose cotransporter 2 inhibitors in combination therapy for type 2 diabetes mellitus.
    Guthrie RM.
    Postgrad Med; 2015 Jun 17; 127(5):463-79. PubMed ID: 25956345
    [Abstract] [Full Text] [Related]

  • 5. Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.
    Scherbaum WA.
    Diabetes Obes Metab; 2009 May 17; 11 Suppl 2():1-2. PubMed ID: 19385977
    [No Abstract] [Full Text] [Related]

  • 6. [Management of Type 2 Diabetes: a Practical Approach].
    Donath M.
    Praxis (Bern 1994); 2016 Jun 08; 105(12):699-702. PubMed ID: 27269776
    [Abstract] [Full Text] [Related]

  • 7. Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale.
    Yassin SA, Aroda VR.
    Drug Des Devel Ther; 2017 Jun 08; 11():923-937. PubMed ID: 28356718
    [Abstract] [Full Text] [Related]

  • 8. Combination therapy of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: rationale and evidences.
    Singh AK, Singh R.
    Expert Rev Clin Pharmacol; 2016 Jun 08; 9(2):229-40. PubMed ID: 26589238
    [Abstract] [Full Text] [Related]

  • 9. Diabetes Update: New Pharmacotherapy for Type 2 Diabetes.
    Choby B.
    FP Essent; 2017 May 08; 456():27-35. PubMed ID: 28530382
    [Abstract] [Full Text] [Related]

  • 10. Managing hyperglycemia in patients with type 2 diabetes mellitus: rationale for the use of dipeptidyl peptidase-4 inhibitors in combination with other oral antidiabetic drugs.
    Freeman JS.
    J Am Osteopath Assoc; 2010 Sep 08; 110(9):528-37. PubMed ID: 20876838
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P, Sitagliptin Study 035 Group.
    Diabetes Obes Metab; 2007 Sep 08; 9(5):733-45. PubMed ID: 17593236
    [Abstract] [Full Text] [Related]

  • 12. Is an SGLT2 inhibitor right for your patient with type 2 diabetes?
    Lisenby KM, Meyer A, Slater NA.
    J Fam Pract; 2016 Sep 08; 65(9):587-93. PubMed ID: 27672684
    [Abstract] [Full Text] [Related]

  • 13. Clinical decisions. Management of type 2 diabetes--polling results.
    Schulte JM, Rothaus CS, Adler JN.
    N Engl J Med; 2014 Jan 02; 370(1):e2. PubMed ID: 24382086
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glyxambi--a new combination for type 2 diabetes.
    Med Lett Drugs Ther; 2015 Apr 27; 57(1467):65-6. PubMed ID: 25897551
    [No Abstract] [Full Text] [Related]

  • 18. The backbone of oral glucose-lowering therapy: time for a paradigm shift?
    Seufert J.
    Fundam Clin Pharmacol; 2009 Dec 27; 23(6):651-67. PubMed ID: 19469803
    [Abstract] [Full Text] [Related]

  • 19. Comparing the efficacy and safety profile of sitagliptin versus glimepiride in patients of type 2 diabetes mellitus inadequately controlled with metformin alone.
    Srivastava S, Saxena GN, Keshwani P, Gupta R.
    J Assoc Physicians India; 2012 Mar 27; 60():27-30. PubMed ID: 22799111
    [Abstract] [Full Text] [Related]

  • 20. [Gliptin-gliflozin combination for treating type 2 diabetes].
    Scheen AJ, Paquot N.
    Rev Med Suisse; 2016 Aug 24; 12(527):1384-1388. PubMed ID: 28671793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.